Welcome to our dedicated page for Amer Shared Hosp news (Ticker: AMS), a resource for investors and traders seeking the latest updates and insights on Amer Shared Hosp stock.
American Shared Hospital Services (AMS: NYSE) delivers innovative financing solutions for advanced cancer treatment technologies, including Gamma Knife radiosurgery and proton beam therapy systems. This page provides investors and healthcare professionals with timely updates on AMS's strategic partnerships, financial performance, and technology deployments.
Access curated press releases and news articles covering AMS's domestic operations and international joint ventures in Latin America. Track developments in radiation therapy financing, equipment upgrades, and oncology service expansions. Our repository ensures stakeholders stay informed about AMS's role in making cutting-edge cancer treatment accessible worldwide.
Explore updates on key areas: quarterly earnings reports, collaborations with medical institutions, regulatory milestones, and new technology implementations like Elekta's Esprit systems. Bookmark this page for direct access to verified information supporting informed decisions about AMS's market position and healthcare impact.
American Shared Hospital Services (NYSE American: AMS) reported strong Q2 2024 financial results, with revenue increasing 27% year-over-year to $7.1 million. The company realized a gain of $3.7 million from the strategic acquisition of Rhode Island Radiation Therapy Cancer Centers. Net income attributable to AMS was $3.6 million, or $0.55 per diluted share, compared to a net loss of $111,000 in Q2 2023. Adjusted EBITDA increased to $2,010,000. Key highlights include:
- Gamma Knife procedures increased 10% due to strong international volume
- Proton beam radiation therapy revenue decreased 5%
- Cash at June 30, 2024 was $14.5 million
- Signed a joint venture agreement for a Gamma Knife facility in Guadalajara, Mexico
- Started patient treatments at the new Puebla, Mexico center
American Shared Hospital Services (NYSE American: AMS), a provider of stereotactic radiosurgery and advanced radiation therapy solutions, has announced its second quarter 2024 earnings conference call scheduled for August 14, 2024, at 6:30 PM ET. The company will release its Q2 2024 financial results after market close on the same day. Investors can participate in the call by dialing 844.413.3972 (domestic) or 412.317.5776 (international). A simultaneous webcast will be available on the company's website and www.streetevents.com. A replay of the call will be accessible until August 21, 2024, via phone and the company's website.
American Shared Hospital Services (NYSE American: AMS) has begun patient treatments at its new radiation therapy facility, A.B. Radiocirugía y Radioterapia de Puebla, in Puebla, Mexico. This facility is a joint venture with Guadalupe Amor Y Bien, with AMS holding an 85% ownership stake. The facility features an Elekta Versa HD linear accelerator, upgrading from Guadalupe's previous older equipment.
The new facility serves a population of over six million and offers advanced treatment techniques including IMRT, VMAT, SBRT, and Radiosurgery. This expansion is part of AMS's international strategy, which includes existing Gamma Knife centers in Peru and Ecuador, and a recently announced joint venture in Guadalajara, Mexico.
American Shared Hospital Services (NYSE American: AMS) announced a joint venture with Hospital San Javier to establish a Gamma Knife treatment facility in Guadalajara, Mexico. AMS will hold a 70% ownership in the venture, with HSJ holding the remaining 30%. The facility will upgrade its current Gamma Knife® Perfexion™ system to Elekta's latest Esprit model, enhancing treatment precision and efficiency. This venture marks AMS's fourth international center, expanding their global footprint in cancer treatment. The center aims to provide advanced, noninvasive brain treatments to a large patient population in Mexico. This collaboration is expected to bring superior radiosurgery solutions to the region.
GK Financing (GKF), a subsidiary of American Shared Hospital Services (AMS), has extended its agreement with PeaceHealth Sacred Heart Medical Center at RiverBend in Springfield, Oregon. The new 10-year agreement includes upgrading the existing Gamma Knife® Perfexion™ system to Elekta's latest Esprit system. The upgrade, expected to be completed by October 1, aims to enhance precision in treating intracranial tumors while minimizing impact on healthy tissue. The Esprit system offers superior visualization, remote treatment planning, and collaboration tools, improving workflow efficiency and patient outcomes.
American Shared Hospital Services (NYSE American: AMS) announced that its Annual Meeting of Shareholders will be held on Tuesday, June 25, 2024, at 9:00 a.m. PT. The meeting will take place in person at The Hilton Hotel in San Francisco, CA. The company provides turnkey technology solutions for stereotactic radiosurgery and advanced radiation therapy equipment and services. The Board of Directors has set April 26, 2024, as the record date for shareholders entitled to notice and voting rights at the meeting.
American Shared Hospital Services (AMS) announced its Q1 2024 financial results, highlighting a record projected revenue backlog of $210 million following the acquisition of Rhode Island Radiation Therapy Cancer Centers. Total revenue for Q1 reached $5.2 million, a 5.9% increase year-over-year, with proton beam radiation therapy revenue up by 14.5%. Gamma Knife revenue slightly decreased by 1.7%. Gross margin improved by 12.3% to $2.1 million. However, operating loss stood at $85,000 compared to a $98,000 operating income in Q1 2023, mainly due to $377,000 in acquisition-related fees. Adjusted EBITDA was $1.74 million, down from $1.90 million the previous year. Cash reserves decreased to $13.04 million from $13.80 million at the end of 2023. Despite increased selling and administrative costs, AMS remains optimistic about future growth driven by new international and domestic centers.
American Shared Hospital Services (AMS) has acquired a 60% majority interest in three radiation therapy cancer centers in Rhode Island, adding $9-$10 million in annual revenue with a positive net income contribution. The acquisition more than doubles the revenue backlog to over $210 million, expanding the company's U.S. footprint and product offering.
American Shared Hospital Services (AMS) will hold a conference call to discuss its first quarter 2024 financial results on May 14th. Investors can dial in or join the webcast to get insights into the Company's performance.